KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenon Pharmaceuticals (XENE) Change in Accured Expenses (2016 - 2025)

Xenon Pharmaceuticals (XENE) has disclosed Change in Accured Expenses for 13 consecutive years, with $41000.0 as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses fell 99.52% to $41000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.2 million through Dec 2025, down 62.5% year-over-year, with the annual reading at $3.2 million for FY2025, 62.5% down from the prior year.
  • Change in Accured Expenses for Q4 2025 was $41000.0 at Xenon Pharmaceuticals, down from $6.1 million in the prior quarter.
  • The five-year high for Change in Accured Expenses was $9.2 million in Q2 2024, with the low at -$5.8 million in Q1 2022.
  • Average Change in Accured Expenses over 5 years is $1.3 million, with a median of $1.5 million recorded in 2022.
  • The sharpest move saw Change in Accured Expenses skyrocketed 875.05% in 2021, then tumbled 744.78% in 2024.
  • Over 5 years, Change in Accured Expenses stood at $3.8 million in 2021, then soared by 60.14% to $6.0 million in 2022, then tumbled by 61.76% to $2.3 million in 2023, then skyrocketed by 270.75% to $8.5 million in 2024, then crashed by 99.52% to $41000.0 in 2025.
  • According to Business Quant data, Change in Accured Expenses over the past three periods came in at $41000.0, $6.1 million, and $869000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.